Surrozen, Inc./DE
Biotechnology company · South San Francisco, California, United States · Nasdaq: SRZN
Surrozen, Inc./DE is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker SRZN. It has reported private securities offerings to the US SEC, most recently $76 million sold in a notice filed in 2025.
Surrozen, Inc./DE at a glance
What does Surrozen, Inc./DE do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $76.4 million sold (2025).
Frequently asked questions about Surrozen, Inc./DE
Where is Surrozen, Inc./DE headquartered?
Surrozen, Inc./DE is headquartered in South San Francisco, California, United States.
What does Surrozen, Inc./DE do?
Surrozen, Inc./DE is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Surrozen, Inc./DE a public company?
Yes. Surrozen, Inc./DE trades on Nasdaq under the ticker SRZN.
When was Surrozen, Inc./DE founded?
The earliest incorporation on record for Surrozen, Inc./DE is in 2021, according to public company registers.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences